**Core Concept**
The question is testing the anticholinergic activity of H1 blockers, which refers to their ability to block the action of acetylcholine at muscarinic receptors in the central and peripheral nervous system. Anticholinergic activity can lead to various side effects such as dry mouth, blurred vision, and urinary retention.

**Why the Correct Answer is Right**
The correct answer is **D. Diphenhydramine**, which is a first-generation H1 blocker known for its high anticholinergic activity. This is due to its ability to cross the blood-brain barrier and interact with muscarinic receptors in the central nervous system, leading to central anticholinergic effects. Diphenhydramine's anticholinergic activity is also responsible for its sedative and hypnotic effects.

**Why Each Wrong Option is Incorrect**
* **Option A:** may be a first-generation H1 blocker, but its anticholinergic activity is not as high as Diphenhydramine's. It may have some anticholinergic effects, but they are not as pronounced.
* **Option B:** is a second-generation H1 blocker, which means it has lower anticholinergic activity compared to first-generation blockers like Diphenhydramine. It is designed to be less sedating and have fewer anticholinergic side effects.
* **Option C:** is another first-generation H1 blocker, but its anticholinergic activity is not as high as Diphenhydramine's. It may have some anticholinergic effects, but they are not as pronounced.

**Clinical Pearl / High-Yield Fact**
When prescribing H1 blockers, it's essential to consider their anticholinergic activity and potential side effects, especially in patients with urinary retention or other conditions that may be exacerbated by anticholinergic effects.

**Correct Answer:** D. Diphenhydramine